Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17β-estradiol in breast cancer cells

Endocrinology

Volumn 144, Issue 6, 2003, Pages 2325-2335

  Khan, Shaheen ^a   Abdelrahim, Maen ^a   Samudio, Ismael ^a   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE CARBAMOYLTRANSFERASE; CAD PROTEIN; CARBAMOYL PHOSPHATE SYNTHASE; DIHYDROOROTASE; ESTRADIOL; ESTROGEN RECEPTOR; LUCIFERASE; TRANSCRIPTION FACTOR SP1;

BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CELL STRAIN ZR 75; CONFERENCE PAPER; CONTROLLED STUDY; E BOX ELEMENT; GC RICH SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MUTATIONAL ANALYSIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

ASPARTATE CARBAMOYLTRANSFERASE; BREAST NEOPLASMS; CARBAMOYL-PHOSPHATE SYNTHASE (GLUTAMINE-HYDROLYZING); DIHYDROOROTASE; DNA MUTATIONAL ANALYSIS; ESTRADIOL; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIENZYME COMPLEXES; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; SP1 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED;

EID: 0037562871     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-0149     Document Type: Conference Paper

References (63)

1. Clark JH 1998 Female reproduction and toxicology of estrogens. In: Korach KS, ed. Reproductive and developmental toxicology. New York: Marcel Dekker; 259-275
2. Turner RT, Riggs BL, Spelsberg TC 1994 Skeletal effects of estrogen. Endocr Rev 15:275-300
3. Chow J, Tobias JH, Colston KW 1992 Estrogen maintains trabecular bone volume in rats not only by suppression of bone resorption but also by stimulation of bone formation. J Clin Invest 89:74-78
4. Farhat MY, Lavigne MC, Ramwell PW 1996 The vascular protective effects of estrogen. FASEB J 10:615-624
5. Hulka BS, Liu ET, Lininger RA 1994 Steroid hormones and risk of breast cancer. Cancer 74:1111-1124
6. Clemons M, Goss P 2001 Estrogen and the risk of breast cancer. N Engl J Med 344:276-285
7. Dickson RB, Lippman ME 1995 Growth factors in breast cancer. Endocr Rev 16:559-589
8. Briand P, Lykkesfeldt AE 2001 An in vitro model of human breast carcinogenesis: epigenetic aspects. Breast Cancer Res Treat 65:179-187
9. Levenson AS, Jordan VC 1997 MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res 57:3071-3078
10. Soule HD, Vazguez J, Long A, Albert S, Brennan M 1973 A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409-1416
11. Brooks SC, Locke ER, Soule HD 1973 Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J Biol Chem 248:6251-6253
12. Lippman ME, Bolan G 1975 Oestrogen-responsive human breast cancer in long term tissue culture. Nature 256:592-593
13. Aitken SC, Lippman ME 1982 Hormonal regulation of net DNA synthesis in MCF-7 human breast cancer cells in tissue culture. Cancer Res 42:1727-1735
14. Aitken SC, Lippman ME 1983 Hormonal regulation of de nevo pyrimidine synthesis and utilization in human breast cancer cells in tissue culture. Cancer Res 43:4681-4690
15. Aitken SC, Lippman ME 1985 Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture. Cancer Res 45:1611-1620
16. Bronzert DA, Monaco ME, Pinkus L, Aitken S, Lippman ME 1981 Purification and properties of estrogen-responsive cytoplasmic thymidine kinase from human breast cancer. Cancer Res 41:604-610
17. Aitken SC, Lippman ME, Kasid A, Schoenberg DR 1985 Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells. Cancer Res 45:2608-2615
18. Lippman ME, Dickson RB 1989 Mechanisms of growth control in normal and malignant breast epithehum. Recent Prog Horm Res 45:383-440
19. Kasid A, Davidson NE, Gelmann EP, Lippman ME 1986 Transcriptional control of thymidine kinase gene expression by estrogens and antiestrogens in MCF-7 human breast cancer cells. J Biol Chem 261:5562-5567
20. Safe S 2001 Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitam Horm 62:231-252
21. Porter W, Saville B, Hoivik D, Safe S 1997 Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol 11:1569-1580
22. Wang F, Hoivik D, Pollenz R, Safe S 1998 Functional and physical interactions between the estrogen receptor-Sp1 and the nuclear aryl hydrocarbon receptor complexes. Nucleic Acids Res 26:3044-3052
23. Sun G, Porter W, Safe S 1998 Estrogen-induced retinoic acid receptor α1 gene expression: role of estrogen receptor-Sp1 complex. Mol Endocrinol 12:882-890
24. Duan R, Porter W, Safe S 1998 Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology 139:1981-1990
25. Xie W, Duan R, Safe S 1999 Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions. Endocrinology 140:219-227
26. Qin C, Singh P, Safe S 1999 Transcriptional activation of insulin-like growth factor binding protein 4 by 17β-estradiol in MCF-7 cells: role of estrogen receptor-Sp1 complexes. Endocrinology 140:2501-2508
27. Wang W, Dong L, Saville B, Safe S 1999 Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions. Mol Endocrinol 13:1373-1387
28. Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Kladde M, Vyhlidal C, Safe S 1999 Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells. J Biol Chem 174:32099-32107
29. Xie W, Duan R, Chen I, Samudio I, Safe S 2000 Transcriptional activation of thymidylate synthase by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinology 141:2439-2449
30. Castro-Rivera E, Samudio I, Safe S 2001 Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J Biol Chem 276:30853-30861
31. Samudio I, Vyhlidal C, Wang F, Stoner M, Chen I, Kladde M, Barhoumi R, Burghardt R, Safe S 2001 Transcriptional activation of DNA polymerase α gene expression in MCF-7 cells by 17β-estradiol. Endocrinology 142:1000-1008
32. Wang F, Samudio I, Safe S 2002 Transcriptional activation of rat creatine kinase B by 17β-estradiol in MCF-7 cells involves an estrogen responsive element and GC-rich sites. J Cell Biochem 84:156-172
33. Wang F, Samudio I, Safe S 2001 Transcriptional activation of cathepsin D gene expression by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Mol Cell Endocrinol 172:91-103
34. Porter W, Wang F, Wang W, Duan R, Safe S 1996 Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Mol Endocrinol 10:1371-1378
35. Vyhlidal C, Samudio I, Kladde M, Safe S 2000 Transcriptional activation of transforming growth factor α by estradiol: requirement for both a GC-rich site and an estrogen response element half-site. J Mol Endocrinol 24:329-338
36. Salvatori L, Ravenna L, Felli MP, Cardillo MR, Russo MA, Frati L, Gulino A, Petrangeli E 2000 Identification of an estrogen-mediated deoxyribonucleic acid-binding independent transactivation pathway on the epidermal growth factor receptor gene promoter. Endocrinology 141:2266-2274
37. Petz LN, Nardulli AM 2000 Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter. Mol Endocrinol 14:972-985
38. Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H 2000 The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial ceils. J Biol Chem 275:25781-25790
39. Li C, Briggs MR, Ahlborn TE, Kraemer FB, Liu J 2001 Requirement of Sp1 and estrogen receptor α interaction in 17β-estradiol-mediated transcriptional activation of the low density, lipoprotein receptor gene expression. Endocrinology 142:1546-1553
40. Mac SM, Farnham PJ 2000 CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines. Mol Carcinog 27:84-96
41. Cavailles V, Garcia M, Rochefort H 1989 Regulation of cathepsin D and pS2 gene expression by growth factors in MCF-7 human breast cancer cells. Mol Endocrinol 3:552-558
42. Cavailles V, Augereau P, Rochefort H 1993 Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription. Proc Natl Acad Sci USA 90:203-207
43. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J, Kushner PJ, Scanlan TS 1997 Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 277:1508-1510
44. Webb P, Lopez GN, Uht RM, Kushner PJ 1995 Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 9:443-456
45. Dubik D, Shiu RPC 1988 Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells. J Biol Chem 263:12705-12708
46. Sathya G, Li W, Klinge CM, Anolik JH, Hilf R, Bambara RA 1997 Effects of multiple estrogen responsive elements, their spacing and location on estrogen response of reporter genes. Mol Endocrinol 11:1994-2003
47. Savouret JF, Bailly A, Misrahi M, Rarch C, Redeuilh G, Chauchereau A, Milgrom E 1991 Characterization of rite hormone responsive element involved in the regulation of the progesterone receptor gene. EMBO J 10:1875-1883
48. Berry M, Nunez A-M, Chambon P 1989 Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc Natl Acad Sci USA 86:1218-1222
49. Weisz A, Rosales R 1990 Identification of an estrogen response element up-stream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res 18:5097-5106
50. Zacharewski TR, Bondy KL, McDonell P, Wu ZF 1994 Antiestrogenic effects of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res 54:2707-2713
51. Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson J-A, Safe S 2000 Ligand-, cell- and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements. J Biol Chem 275:5379-5387
52. Porter W, Wang F, Duan R, Qin C, Castro-Rivera E, Safe S 2001 Transcriptional activation of heat shock protein 27 gene expression by 17β-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists: estrogenic activity of ICI 164, 384. J Mol Endocrinol 26:31-42
53. Boyd KE, Farnham PJ 1999 Coexamination of site-specific transcription factor binding and promoter activity in living cells. Mol Cell Biol 19:8393-8399
54. Boyd KE, Farnham PJ 1997 Myc versus USF: discrimination at the cad gene is determined by core promoter elements. Mol Cell Biol 17:2529-2537
55. Boyd KE, Wells J, Gutman J, Bartley SM, Farnham PJ 1998 c-Myc target gene specificity, is determined by a post-DNA-binding mechanism. Proc Natl Acad Sci USA 95:13887-13892
56. Xing W, Archer TK 1998 Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter. Mol Endocrinol 12:1310-1321
57. Abdelrahim M, Samudio I, Smith R, Burghardt R, Safe S 2002 Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J Biol Chem 277:28815-28822
58. DiRenzo J, Shang Y, Phelan M, Sif S, Myers M, Kingston R, Brown M 2000 BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 20:7541-7549
59. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
60. Graves LM, Guy HI, Kozlowski P, Huang M, Lazarowski E, Pope RM, Collins MA, Dahlstrand EN, Earp HS, Evans DR 2000 Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature 403:328-332
61. Dubik D, Dembinski TC, Shiu RPC 1987 Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res 47:6517-6521
62. Watson PH, Pon RT, Shiu RPC 1991 Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identities a critical role for c-myc in the growth of human breast cancer. Cancer Res 51:3996-4000
63. Wosikowski K, Eppenberger U, Kung W, Nagamine Y, Mueller H 1992 c-fos, c-jun and c-myc expressions are not growth rate limiting for the human MCF-7 breast cancer cells. Biochem Biophys Res Commun 188:1067-1076